Limits...
Pharmaceutical Cocrystals and Their Physicochemical Properties.

Schultheiss N, Newman A - Cryst Growth Des (2009)

Bottom Line: This review article will highlight and discuss the advances made over the last 10 years pertaining to physical and chemical property improvements through pharmaceutical cocrystals and, hopefully, draw closer the fields of crystal engineering and pharmaceutical sciences.

View Article: PubMed Central - PubMed

Affiliation: SSCI, Inc., A Division of Aptuit, West Lafayette, Indiana, and Seventh Street Development Group, Lafayette, Indiana.

ABSTRACT
This review article will highlight and discuss the advances made over the last 10 years pertaining to physical and chemical property improvements through pharmaceutical cocrystals and, hopefully, draw closer the fields of crystal engineering and pharmaceutical sciences.

No MeSH data available.


Possible multicomponent systems: cocrystals, salt cocrystals, and salts along with their respective solvate/hydrate forms.
© Copyright Policy - open-access - ccc-price
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2690398&req=5

fig2: Possible multicomponent systems: cocrystals, salt cocrystals, and salts along with their respective solvate/hydrate forms.

Mentions: (1) An API, neutral (example 1, Figure 2), or ionic form (example 2, Figure 2, or a zwitterion), along with a neutral coformer, held together through noncovalent, freely reversible interactions,


Pharmaceutical Cocrystals and Their Physicochemical Properties.

Schultheiss N, Newman A - Cryst Growth Des (2009)

Possible multicomponent systems: cocrystals, salt cocrystals, and salts along with their respective solvate/hydrate forms.
© Copyright Policy - open-access - ccc-price
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2690398&req=5

fig2: Possible multicomponent systems: cocrystals, salt cocrystals, and salts along with their respective solvate/hydrate forms.
Mentions: (1) An API, neutral (example 1, Figure 2), or ionic form (example 2, Figure 2, or a zwitterion), along with a neutral coformer, held together through noncovalent, freely reversible interactions,

Bottom Line: This review article will highlight and discuss the advances made over the last 10 years pertaining to physical and chemical property improvements through pharmaceutical cocrystals and, hopefully, draw closer the fields of crystal engineering and pharmaceutical sciences.

View Article: PubMed Central - PubMed

Affiliation: SSCI, Inc., A Division of Aptuit, West Lafayette, Indiana, and Seventh Street Development Group, Lafayette, Indiana.

ABSTRACT
This review article will highlight and discuss the advances made over the last 10 years pertaining to physical and chemical property improvements through pharmaceutical cocrystals and, hopefully, draw closer the fields of crystal engineering and pharmaceutical sciences.

No MeSH data available.